United-Guardian, Inc. manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, healthcare products, and specialty industrial products in the United States and internationally.
Flawless balance sheet with acceptable track record.
Share Price & News
How has United-Guardian's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: UG's share price has been volatile over the past 3 months.
7 Day Return
US Personal Products
1 Year Return
US Personal Products
Return vs Industry: UG underperformed the US Personal Products industry which returned 15.7% over the past year.
Return vs Market: UG underperformed the US Market which returned 17.9% over the past year.
Price Volatility Vs. Market
How volatile is United-Guardian's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StShould We Be Delighted With United-Guardian, Inc.'s (NASDAQ:UG) ROE Of 34%?
3 weeks ago | Simply Wall StShould You Like United-Guardian, Inc.’s (NASDAQ:UG) High Return On Capital Employed?
1 month ago | Simply Wall StHere's What United-Guardian, Inc.'s (NASDAQ:UG) P/E Is Telling Us
Is United-Guardian undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: UG ($16.17) is trading below our estimate of fair value ($22.3)
Significantly Below Fair Value: UG is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: UG is poor value based on its PE Ratio (18.8x) compared to the Personal Products industry average (16x).
PE vs Market: UG is poor value based on its PE Ratio (18.8x) compared to the US market (18.2x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate UG's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: UG is overvalued based on its PB Ratio (6.3x) compared to the US Personal Products industry average (1.9x).
How is United-Guardian forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Household industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as United-Guardian has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine United-Guardian's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- Explore growth companies in the Household industry.
How has United-Guardian performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: UG has high quality earnings.
Growing Profit Margin: UG's current net profit margins (30.7%) are lower than last year (34.4%).
Past Earnings Growth Analysis
Earnings Trend: UG's earnings have grown by 0.2% per year over the past 5 years.
Accelerating Growth: UG's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: UG had negative earnings growth (-17.3%) over the past year, making it difficult to compare to the Personal Products industry average (21.4%).
Return on Equity
High ROE: UG's Return on Equity (33.6%) is considered high.
Return on Assets
Return on Capital Employed
How is United-Guardian's financial position?
Financial Position Analysis
Short Term Liabilities: UG's short term assets ($12.7M) exceed its short term liabilities ($1.5M).
Long Term Liabilities: UG's short term assets ($12.7M) exceed its long term liabilities ($234.7K).
Debt to Equity History and Analysis
Debt Level: UG is debt free.
Reducing Debt: UG has not had any debt for past 5 years.
Debt Coverage: UG has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: UG has no debt, therefore coverage of interest payments is not a concern.
Inventory Level: UG has a low level of unsold assets or inventory.
Debt Coverage by Assets: Insufficient data to determine if UG's debt is covered by short term assets.
What is United-Guardian's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: UG's dividend (6.8%) is higher than the bottom 25% of dividend payers in the US market (1.45%).
High Dividend: UG's dividend (6.8%) is in the top 25% of dividend payers in the US market (3.73%)
Stability and Growth of Payments
Stable Dividend: UG's dividend payments have been volatile in the past 10 years.
Growing Dividend: UG's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (127.8%), UG's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ken Globus (67yo)
Mr. Kenneth H. Globus, also known as Ken, has been the Chairman at United-Guardian Inc. since September 2009 and its Chief Executive Officer since December 2006. Mr. Globus has been President and General C ...
CEO Compensation Analysis
Compensation vs Market: Ken's total compensation ($USD422.25K) is about average for companies of similar size in the US market ($USD522.48K).
Compensation vs Earnings: Ken's compensation has been consistent with company performance over the past year.
|Executive VP||38.1yrs||US$122.79k||0.11% $83.1k|
|VP & Production Manager||38.1yrs||US$210.39k||0.0070% $5.2k|
|CFO, Treasurer & Controller||1.8yrs||no data||no data|
|R&D Manager and Director of Technical Services||1.9yrs||no data||no data|
|Controller & Accounting Manager||9.5yrs||no data||no data|
Experienced Management: UG's management team is seasoned and experienced (10 years average tenure).
|Executive VP||38.1yrs||US$122.79k||0.11% $83.1k|
|Independent Director||22.8yrs||US$33.00k||0.27% $196.9k|
|Independent Director||26yrs||US$44.00k||0.087% $64.7k|
|Independent Director||17.3yrs||US$29.50k||no data|
|Independent Director||3.9yrs||US$27.50k||no data|
Experienced Board: UG's board of directors are seasoned and experienced ( 20 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
United-Guardian, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: United-Guardian, Inc.
- Ticker: UG
- Exchange: NasdaqGM
- Founded: 1942
- Industry: Personal Products
- Sector: Household
- Market Cap: US$74.290m
- Shares outstanding: 4.59m
- Website: https://www.u-g.com
Number of Employees
- United-Guardian, Inc.
- 230 Marcus Boulevard
- PO Box 18050
- New York
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|UG||NasdaqGM (Nasdaq Global Market)||Yes||Common Stock||US||USD||Jan 1980|
United-Guardian, Inc. manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, healthcare products, and specialty industrial products in the United States and internationally. It offers personal care products, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL II XD; ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics; LUBRASLIDE and B-122 powdered lubricants used in the manufacture of pressed powders, eyeliners, and rouges; LUBRAJEL PF, a preservative-free form of LUBRAJEL; LUBRAJEL NATURAL, natural products for cosmetic use; KLENSOFT, a surfactant used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and LUBRASIL, a special form of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base. The company’s medical products comprise LUBRAJEL RR and RC lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC, LUBRAJEL FA, and LUBRAJEL BA, which are LUBRAJEL formulations for oral use; and LUBRAJEL FLUID to lubricate water-soluble products. Its pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder. The company’s industrial products include DESELEX liquid, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based cleanser. It also conducts research and product development for the development of cosmetic and personal care products. The company markets its products through marketing partners, distributors, and wholesalers. United-Guardian, Inc. was founded in 1942 and is headquartered in Hauppauge, New York.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/23 00:40|
|End of Day Share Price||2020/02/21 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.